Medicine
Trintellix 5 mg tablet
Trintellix 5 mg tablet is a prescription medicine containing Vortioxetine for oral use, marketed by Takeda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 77°F (25°C), excursions permitted to 59°F to 86°F (15°C to 30°C).
Key facts
- Active ingredient (INN)
- Vortioxetine
- Brand
- Trintellix
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 bottle, 30 tablets, 500 tablets and 4 more
- Marketing authorisation holder
- Takeda Pharmaceuticals
- Manufacturers
- Takeda PharmaceuticalsRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Store at 77°F (25°C), excursions permitted to 59°F to 86°F (15°C to 30°C).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX26 Vortioxetine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 October 2013
- Identifiers
- RxCUI 1439808, 1439810, 1439812 +3DailyMed set ID 1a5b68e2-14d0-419d-9ec6-1ca97145e838, bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4eNDC 64764-720, 70518-4483Application NDA204447
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 7 tablet, film coated in 1 bottle | 64764-720-07 | Takeda Pharmaceuticals | 2 October 2013 |
| 30 tablet, film coated in 1 bottle | 64764-720-09 | Takeda Pharmaceuticals | 2 October 2013 |
| 30 tablet, film coated in 1 bottle | 64764-720-30 | Takeda Pharmaceuticals | 2 October 2013 |
| 500 tablet, film coated in 1 bottle | 64764-720-77 | Takeda Pharmaceuticals | 2 October 2013 |
| 90 tablet, film coated in 1 bottle | 64764-720-90 | Takeda Pharmaceuticals | 2 October 2013 |
| 30 pouch in 1 box / 1 tablet, film coated in 1 pouch | 70518-4483-0 | Remedyrepack | 24 September 2025 |
| 50 pouch in 1 box / 1 tablet, film coated in 1 pouch | 70518-4483-2 | Remedyrepack | 23 April 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Vortioxetine
Clinical summary
Vortioxetine is a prescription medicine indicated for the treatment of major depressive disorder (MDD) in adults. It is available as tablets for oral use. MedsAcross supplies Vortioxetine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VortioxetineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Trintellix prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Brintellix: European public assessment report (EPAR) · European Medicines Agency
Need Trintellix 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.